|
|
|
BIOMEDICAL
TECHNOLOGY
|
| BIOMEDICAL
ENGINEERING GROUP |
|
Artificial Organs Division
The Artificial Organs division is engaged
in the development of implants and other
associated medical devices. This division
has its core strength in the area of design,
prototyping, in vitro evaluation, process
development and technology documentation
for medical devices. The facilities and
expertise are available in the areas of
design and drawing generation, polishing
of medical device components and automated
instrumentation development for devices.
Modeling & Prototyping Laboratory and
Devices Testing laboratory function as part
of this division.
|
|
Device Testing Laboratory
This laboratory has the core competence
in development of systems and methodologies
directly related to evaluation of medical
devices.
|
|
Modeling & Prototyping Laboratory
The laboratory holds the core strength in
modeling, prototyping and process development
activities related to medical device development.
|
|
Dental Products Laboratory
Dental
Products laboratory has already developed
and transferred technologies of various
dental materials such as dental composites,
dentine bonding agent and single solution
bonding agent to industry which are marketed
under the brand names Restofill, Stedbond
and Stedbond S. Currently the laboratory is
engaged in the development of glass ionomer
cement, caries dissolving agents, nano and
organically modified ceramic composites for
dental applications, intrauterine drug
releasing systems and polymer scaffolds for
tissue engineering. The other activities
include spectroscopic evaluation using FT
Raman for atherosclerosis, microcomputerised
tomograhic analysis (Micro CT) of polymer
scaffolds, ceramics, bone implants and
dental tissues.
|
|
Instrumentation Laboratory
This laboratory is equipped with basic facilities
required for research and development in
medical instrumentation and its activity
includes technology development in medical
transducers and bio-electrodes, development
of bio-electrical impedence measurement
techniques and novel diagnostic tools such
as those required for artifact free monitoring
of breathing and early detection of cancer
|
|
Polymer Processing Division
This division is engaged in the development
of polymer compounds for variety of biomedical
applications. The division has facilities
for formulation, development, processing
and testing of polymer materials. The processing
capability includes extrusion of sheet,
tube and rods. The current activities include
development of polymer-ceramic composites
for bone substitute applications, lubricious
coating for urinary latex catheters, development
of non-toxic formulations for various biomedical
products.
|
|
Technology Proving Facility
This is a 3200 sq. ft Class 10000 clean
room facility with basic infrastructure
like cleaning, drying, assembling, packing
and sterilisation for the scale-up production
of medical devices and serves as a link
between the Institute and the industry during
the technology transfer.
|
|
Precision Fabrication Facility
Precision Fabrication Facility has the
capability of design, development and
inspection of mechanical systems, prototype
development and pilot production. In
addition to conventional machines, CNC
Lathe, milling, Spark Erosion and Wire EDM
machines are also available.
|
|
|
|
|